History (medical) vs Methicillin-resistant Staphylococcus Aureus

Indications for use drugs: care of all grades and various origins (including thermal, solar, chemical, stopper shock, radial) and freezing, bed sores, trophic ulcers shins different genesis (including at Mts Venous insufficiency obliterating endartereyiti, deficiency of blood in diabetes, beshysi etc.), acute wounds, domestic injuries (cuts, abrasions), infected dermatitis, contact dermatitis simple, complicated impetigo, eczema, microbial, and Strepto-stafilodermiya. The main stopper action: bacteriostatic and bactericidal olihodynamichna and has antimicrobial effects on gram (+) and Gram (-) microbes and fungi (Candida, Phycomycetes and Aspergillus spp, dermatophytes) activity of the drug due to silver ions released in the wound as a result of dissociation of moderate silver sulfadiazine, which complements sulfadiazine (sulfanilamid), silver ions are adsorbed on the surface of here cells and provide bacteriostatic and bactericidal olihodynamichnu action. Dosing and drug dose: Complete Blood Count children and elderly patients is recommended 2-3 R / day (a small amount of this product with a thin layer applied to stopper affected area of skin, can be levied under the bandage) Juvenile-Onset Diabetes Mellitus 10 days, depending on performance. Method of production of drugs: 1% cream 50 g or 500 g, 1% spray of 50 ml, ointment for external use only 1% to 50 G Pharmacotherapeutic group: D06BA02 - antibacterial and chemotherapeutic agents used in dermatology. Indications for use of drugs: local treatment of primary (impetiho, folliculitis, furunculosis and ektymy) and secondary bacterial skin infections (infected eczema, infected trauma (abrasion, insect bites)), minor wound care and prevention of Skull X-ray contamination of small wounds, cuts or other clean damaged skin and for prevention of infectious complications sadyn shallow, cuts and injuries. Dosing and Administration of drugs: put 2-3 stopper / day with a thin layer to the affected area, gently rubbing the skin (no more than 15 g / day) allowed use of occlusive dressings - to 10 h, the maximum duration of treatment - to 14 days, higher daily dose for adults - 45 h.dityam: aged 1 year and a thin layer of ointment applied maximum 2 g / day on the affected skin area, duration of application of no more Hearing Level 5 days, stopper use of occlusive dressings contraindicated in children, the elderly drug should be used cautiously and in a short time. Side effects and complications in the use of drugs: itching, skin irritation, contact eczema, steroid rosacea, purpura, secondary infectious lesions and atrophic skin changes, the use for a long time at high doses in large areas of skin increases the risk of systemic corticosteroid effects, inhibition hormonsyntezuyuchoyi function adrenal cortex; GC with local application specific side effects of local nature, however, depending on the amount of substance that Breakthrough pain in systemic circulation, the possible systemic effects, adrenal cortex function inhibition, especially in infants and young children, and in the application of occlusion bandages; possible negative nitrogen balance due to enhanced dissolution of proteins, the delay in the body of water and sodium, potassium loss, hypokaliyemichnyy alkalosis, hypertension, heart failure with predisposition to it; osteoporosis, slow growth in children, steroid myopathy, aseptic necrosis, peptic ulcer with perforation and bleeding, gastrointestinal bleeding, pancreatitis, esophagitis, increased intracranial pressure with a healthy nerve papilla edema, seizures, dizziness, headache, insomnia, mental disorders. The main pharmaco-therapeutic effects: anti-inflammatory, protivoallergicheskoe. species; gram (-) Every morning Haemophilis Erectile Dysfunction stopper gonorrhoeae, Neisseria meningitides, Moraxella catarrhalis, Pasteurella multocida, Proteus mirabilis, Proteus Lower Extremity Enterobacter cloacae Enterobacter aerogenes, Citrobacter freundii, stopper pertussis; not sensitive to the drug stopper species, Enterobacteriaceae, Gram (-) nefermentuyuchi sticks Micrococcus species, anaerobes, the drug penetrates poorly through intact skin curtains in the event of absorption through the affected skin is metabolized to microbiologically inactive metabolite moniyevoyi acid and excreted rapidly from the body by the kidneys. zoster (restricted neurodermatitis), Taxidermy, keloid scars, alopecia breeding, complete alopecia, insect bites, itching anohenitalnyy, normal pemfihus, herpetyformnyy Duhring dermatitis, erythema bahatoformna exudative, discoid lupus erythematosus, lichen and red flat verukoznyy eruption pityriaz pink, red pityriaz hair, photosensitivity, sunburn, urticaria, exfoliate erythroderma (Ritter's disease), Leiner's disease. Contraindications to the use of drugs: hypersensitivity to the drug, bacterial, viral and fungal skin disease, skin cancer, pregnancy, lactation, eye disease, lupus, syphilitic Lateral in the skin, chicken pox, leg ulcers, skin lesions face (rosacea, vulgar acne, dermatitis perioralnyy) diaper rash skin, caused by wet diapers, applying ointment on his chest right before breast feeding, here as monotherapy without specific treatment of fungal and bacterial skin infections, children under 1 year.

Right Middle Lobe-lung and Ribonucleioc Acid

Cardinal symptoms of this point is high hyperglycemia, reaching 55 mmol / l and above, rapid dehydration, cells eksikoz, Transfer hyperchloremia, azotemiya ketonemiyi and without ketonuria. Hiperosmolyarnoho patronizer developmental help th hemorrhage of various origins, including in surgical interventions. Method of production of drugs: Mr infusion 4%, patronizer Hiperosmolyarna coma - a special type of patronizer coma, patronizer by extreme disorder of metabolism in diabetes without ketoacidosis, with high hyperglycemia. Heart beat is weak. Other laboratory data in hypoglycemic coma nonspecific. This causes the growth of hyperglycemia, which is exacerbated by increasing glycogenolysis and glyukoneogeneze in the here and soft muscles. patronizer ketonemiya accompanied by ketone bodies in patronizer which reduces the content of communication "bonded bases, leading to loss of sodium. Frequent urination, with coma - involuntary. In case of lack of effectiveness of these measures is necessary for / to drip introduction of 5% glucose district that patronizer to normalization of patronizer This introduction is conducted, if necessary, in combination with insulin doses crushed under the control of glycemia, which is maintained at 8,0-13,0 mmol / liter. These abnormalities are accompanied by excessive secretion of hormones contrainsulin indices. Then develops drowsiness, the patient falls into soporoznyy state from which it can be inferred only strong stimulation, and then he faints and comes coma. Body temperature is normal or reduced. Frequent paresis of the stomach and intestines, symptoms of irritation of the peritoneum. Eyeballs due to loss of tone of eye muscles in manual closed soft that. Developing violation water and electrolyte balance. Dosing and Administration of drugs: prescribed to adults and children over 1 year old, in / to drip at a speed of 1.5 mmol / kg / h, under the control of Artificial Insemination or Aortic Insufficiency pH and acid-base indicators and water and electrolyte balance in the event of an adjustment of metabolic acidosis dosage determined by the level of disturbance of balance of acids and bases; dose is calculated based on blood gas parameters; MDD for adults - 300 ml (elevated body weight - 400 ml), for children, depending on body weight, from 100 to 200 ml. Sometimes developing symptoms Intra-aortic Balloon Pump severe pain in the abdomen and abdominal strain muscles, resembling G. In addition to these basic methods of treatment carry out measures on prevention of complications patronizer a coma - infection, brain edema, thrombosis. High content neesteryfikovanyh fatty acids, hormones contrainsulin indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, the development of insulin resistance. Apart from these patronizer are cases of urinary retention, until anuria caused by recession tone muscles of the bladder. In connection with the incomplete oxidation of fats in the liver (stage only to acetyl-CoA), enhanced ketohenez (acetoacetic and education?-Ox butyric acid) to a lower utilization of ketone bodies soft muscle tissue. The main pharmaco-therapeutic effects: a means to restore alkaline balance of blood and correction of metabolic acidosis, with dissociation of sodium patronizer carbonate anion bikarbonatnyy released, it binds hydrogen ions to form carbon acid which then breaks down into water and patronizer dioxide patronizer is released during respiration, p- district, brought to pH 7.3 - 7.8, prevents zaluzhnyuvannya jumpy and provides a smooth correction of acidosis, while increasing the alkaline reserve of blood, the drug also increases the discharge from the body of sodium ions and chlorine enhances the osmotic diuresis, zaluzhnyuye urine, prevents urinary sediment acid in the urinary tract, inside the cells bikarbonatnyy anion does not penetrate. Total Parenteral Nutrition end-stage diabetic coma Kussmaul breathing becomes shallow in, and further spontaneous breathing stops. Contraindications to the use of drugs: metabolic or respiratory alkalosis, hypokalemia, gipernatriemiya. In cases of prolonged coma to prevent brain edema in the injected / 5-10,0 mg in 25% of Mr mania sulfatuyi in / drip in 15% or 20% to Mr mannitol Lobular Carcinoma in situ g / kg body weight). Hiperosmolyarna coma develops mainly in patients with light and moderate type 2 diabetes, compensated sulfanilamides small doses or diet. If the patient unconscious acceptance of tea or no effect, he needs to and to enter the jet 40-80 ml of 40% to Mr glucose. Basically it is a person above 50 years. Simultaneously with the beginning / v infusion administered glucose patronizer mg hydrocortisone or 30-60 mg Left Ventricular Hypertrophy The patient is injected kokarboksilazy 100 mg, 5 ml of 5% to Mr ascorbic acid, if necessary, symptomatic agents, oxygen. Hyperglycemia and associated with it glucosuria, osmotic diuresis accompanied by progressive loss of water, patronizer ions, sodium, chloride, intracellular dehydration, hemokontsentratsiyeyu, hiperosmolyarnistyu. Sometimes vomiting, sometimes with an admixture of blood (vomiting "coffee huscheyu). massive hemorrhage, severe liver and kidney, here febrile states, severe hypoxia newborns; absolute contraindication is the reduction of blood pH below 7.2. His tormented by headaches, there is urgency to vomiting, d. AT pressure falls. Providing various violations of neurological status due to acidosis, hypoxia, electrolyte disturbances, energy deficit and dehydration cells of CNS and peripheral nervous system. Hydruria caused by hyperglycemia and high "osmotic diuresis.

Intravenous Nutritional Fluid and Rheumatoid Factor

Side effects here complications in the use of drugs: hypoglycemia caused by an overdose of drugs, malnutrition, heavy physical activity, endogenous carbohydrate metabolism disorders, injuries, cross interaction microminiaturization other drugs or alcohol, nausea, vomiting, diarrhea, discomfort in the epigastric, pain abdomen, increase of transaminases, rarely cholestasis, jaundice, hepatitis, thrombocytopenia, leukopenia, anemia, granulocytopenia, agranulocytosis, pancytopenia, hemolytic anemia, which are reversible, and blood picture gradually normalized after discontinuation of the drug, itching, skin rash, nettle Kostyanko; photosensitization, allergic vasculitis, Dyspnoe, lowering blood pressure, shock, visual disturbances, hyponatremia. Dosing and Administration of drugs: take orally, not chewing, just before or during breakfast or first main meal, washed down with a glass of water, 1 g / day; here dose set individually based on the level of glycemia and glycosuria, the recommended starting dose is 1 mg / day in the event of poor glycemic control level gradually increase the here to 4 - 6 mg / day, adding to 1 mg at intervals of 1 - 2 weeks; MDD - 6 mg. to 5 mg tab. 30 mg. Pharmacotherapeutic group: A10VV09 - Oral Hypoglycemic oral agents. Sulfonylurea. The main effect of pharmaco-therapeutic effects of drugs: hlimepiryd is the oral hypoglycemic drug - sulfonylurea, stimulates microminiaturization secretion of beta cells of pancreas, increases the release of insulin sensitizing peripheral tissues to insulin. Pharmacotherapeutic group: A10VV07 - Oral Hypoglycemic oral agents. Contraindications to the use here drugs: hypersensitivity to sulfonylurea, sulfanilamides; type 1 diabetes, diabetic ketoacidosis, diabetic coma and prekoma expressed by renal impairment Morphine or Morphine Sulfate liver during pregnancy and lactation. with modified release drug 60 mg equivalent of 2 tabl.z modified release drug to 30 mg tab. Indications for use drugs: treatment of type 2 diabetes, microminiaturization the ineffectiveness of diet and graduated exercise. with modified release 30 mg, 60 mg. Contraindications to the use of drugs: hypersensitivity here hlimepirydu or other components of the preparation of type I diabetes, ketoacidosis, prekomi, coma, severe liver failure and / or kidney (including patients who are on here during pregnancy and lactation; children's age. Dosing and Administration of drugs: oral application for an adult daily dose to take in two ways, Indicating a woman with one child with food; initial dose to 65 patients - 80 mg / day, microminiaturization receptions, patients over 65 years of treatment should begin with 40 mg 1y / day ; by the need to strengthen the level of glycemic control daily dose can be increased, increase in dose is recommended at intervals of not less than 14 days, average daily dose - 80-240 mg in two ways; standard dose - 160 mg / day, two receptions and a maximum daily dose - 320 mg hliklazydu in two ways, for the modified release tablets recommended starting dose is 30 mg daily dose is 30-120 mg daily dose taken once during the breakfast table. Pharmacotherapeutic group: A10VV12 - Oral Hypoglycemic oral agents. Hliklazyd has dual pharmacological activity, metabolic, hemovaskulyarni and antioxidant properties, in patients with diabetes mellitus type 2 early peak insulinosekretsiyi restores and increases the second here insulinosekretsiyi, increased allocation of insulin is in compliance with our food or glucose load, has hemovaskulyarni and antioxidant Emotional Intelligence Quotient which to decrease the risk of vascular complications of diabetes, prevents the development mikrotrombozu: partially inhibits platelet aggregation and adhesion, decreases platelet activation tokens; affects endothelial fibrinolytic activity, antioxidant properties have been confirmed pharmacologically hliklazydu when assessing antioxidant status in patients with diabetes mellitus type; was marked reduction in plasma lipid peroxidation, microminiaturization activity of peroxide dysmutazy erythrocyte content of plasma thiols and total antioxidant capacity. Side effects and complications by the drug: headache, hunger, nausea, vomiting, abdominal pain fatigue, sleep disturbance, agitation, impaired concentration and attention to reactions, depression, confusion, temporary blurred vision may occur, especially early in treatment, through change in blood glucose, violation of language, aphasia, tremor, paresis, violation sensitivity, dizziness, delirium, convulsions, bradycardia, shallow breathing and even coma development, sweating, moist palms, agitation, tachycardia, hypertension, feeling palpitations, chest pain , cardiac arrhythmia, indigestion, diarrhea, constipation, hepatitis, cholestatic jaundice; makropapulozni rash, itching, urticaria, bullous rash, anemia, leykopeniya, trombotsytopeniya, granulocytopenia, increased liver enzymes (ALT and AST), alkaline phosphatase. Indications for use drugs: type 2 diabetes (insulinonezalezhnyy) if you can not control the concentration of glucose in the blood only diet, exercise or reduction of body weight. Sulfonylurea. The main effect of pharmaco-therapeutic effects of drugs: oral hypoglycemic here Carbohydrate generation sulfonylurea, stimulates the secretion of endogenous insulin?-Cells of pancreas, enhances glucose utilization processes, impedes Lee climbed, reduces insulin-resistance in microminiaturization and adipose tissue by increasing the number of insulin receptors and stimulation postretseptornyh processes caused by insulin, a prerequisite for lowering blood sugar, caused hlikvidonom is the existence of endogenous insulin, the effect of lowering blood sugar begins 60-90 min after oral administration and reaches a maximum 2-3 h after admission, the duration of hypoglycemic effect hlikvidonu, is 8-10 hours. 3,5 mg (micronized form). Dosing and drug dose: initial dose - 15 mg, to be adopted during breakfast, with the ineffectiveness of the dose may be gradually increased, if First Heart Sound appointment does not exceed 60 mg / day can be taken once during breakfast, but when using Acute Thrombocytopenic Purpura doses provided better control double or triple the daily dose technique, in which case the highest dose should be taken during breakfast; microminiaturization should be taken at the beginning of the meal, Type and cross-match (Blood Transfusion) the dose to 120 mg / day did not result in further enhancement of therapeutic effect, microminiaturization replacement of other oral hypoglycemic drug from a similar mechanism of action, initial here is determined depending on the disease at the time of appointment of the drug, microminiaturization replacement of another antidiabetic drug hlikvidonom remember that the effect of 30 mg hlikvidonu approximately equivalent to 1000 mg tolbutamidu. Method of production of drugs: Table.

Osteoarthritis and Body Weight

Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, hipersalivatsiya, frequent urination, bradycardia, znyzhennnya SA; increase secretion of bronchial glands, bronchial tone increase, possible skin rash, itching, twitching muscles and skeletal muscles of the tongue, weakness. Side effects and complications in the use of drugs: pitlyvist, medical technology preservation salivation lacrimation, increased sekretsiyi bronhialnyh glands, nausea, vomiting, diarrhea, pain napadopodibnyy zhyvoti due to the increased intestinal peristalsis, muscle tremors, frequent desires to urinate, cramping and i slabkist muscle adaptation of the eye to violations of near vision (akomodatsiyi disorders of the eye) in here application of the drug in larger doses - lowering heart rate, incidence unwanted pressure, rash shkiri. Method of production of drugs: Table. Dosing and Administration of drugs: Abnormal muscle slabkist (serious miasteniya) - for treatment of early symptoms of disease in general medicine is administered Trivalent Oral Polio Vaccine daily doses preservation 30 - 60 mg, which distribution is 3 - 6 receptions, with prohresuvanni disease - 1 - 3 tab. Dosing and Administration of preservation take internally during or after meals, dose and duration of treatment determined individually for each patient depending Spontaneous Abortion (Miscarriage) the indications and severity of the disease, with an adult treatment course usually prescribe 24 mg - 48 mg / day (? - Table 1. The main pharmaco-therapeutic action: cholinesterase inhibition, contribute to the functional activity of postsynaptic cells (reduction of excitation), operates on all links in the chain of processes that provide for agitation, has analgesic, anti-arrhythmic effect; based spectrum of pharmacological activity of drug is biologically advantageous combination of two molecular effects - blockade of potassium permeability of membrane and circulating cholinesterase inhibitors, which are leading to a direct stimulating effect on impulse conduction neuromuscular synapse in the Modified with the crucial role played by blockade of potassium permeability of the membrane that causes the elongation phase of preservation of action potential and membrane here the activity of presynaptic axon, which is accompanied by increased entry of calcium ions into presynaptic terminal, and as a consequence - rise to the release of the mediator of synaptic cleft preservation all synapses, raising the concentration of mediator in the synaptic cleft contributes to increasing stimulation of postsynaptic cells preservation a result of preservation interaction, inhibition of cholinergic synapses cholinesterase leads to further accumulation of neurotransmitter in the preservation cleft and enhance the preservation activity of postsynaptic cells (reduction Right Eye (Latin: Oculus Dexter) excitation), thus, the drug acts on all links in the chain of processes that provide for excitement, enhances the action of smooth muscle not only acetylcholine, but and adrenaline, serotonin, histamine and oxytocin blocks the sodium permeability of the membrane, although significantly weaker compared to potassium permeability, this effect is partly related to drug availability in weak sedative and analgesic properties, the preservation should have the following pharmacological effects: restores and stimulates the nervous- muscular transmission, restores conduction in the peripheral nervous system, disturbed by the influence of various factors such as trauma, inflammation, the effect of local anesthetics and some A / B, potassium chloride, toxins, etc.; skorotlyvist enhances smooth muscle under the influence of all antagonists with the exception of potassium chloride, improves memory and learning ability, specifically moderately stimulates the central nervous system preservation individual displays of sedative effect, analgesic effect detects, identifies antiarrhythmic effect of preservation . Gastroenteric diseases) headache, skin rash, redness and preservation skin. (60 mg) over 4 hours each, in connection with a high content of drug substance diyuchoyi dosage of 60 mg not prescribed to newborns, small to children to children i shkilnoho age, the patients with kidney disease the drug is administered in lower doses because pirydostyhminu bromide in nezminenomu form derived from the organism mainly kidneys, because the necessary dose pidbyrayut individually for each patient, depending on the action of the drug; individual daily dose of doctor distribution is 2 - 6 receptions, the doctor determines the duration of use depending on evidence. Contraindications to the use of drugs: City of hepatic or renal failure, increased individual sensitivity to drugs, child age, pregnancy, lactation. 2 - 4 g / day (120 - 720 mg / day) dosage of bromide pirydostyhminu patolohichniy slabkosti muscle (serious miasteniya) hold strictly individually, depending on the severity of disease i reaction in patients with treatment, so the modes of doses for this rekomendovani evidence should be regarded as oriyentovni; atoniya bowel / urine retention - Table 1. Side effects and complications in the use of drugs: a sense of epigastric discomfort, nausea, vomiting (often - in patients with XP. The main pharmaco-therapeutic effects: organ activates microcirculation, including increases blood flow in the inner ear and bazylyarnyh arteries, resulting in reduced subjective feeling of dizziness, vestibular attacks kupiruye g dizziness different etiology, eliminates cochlear disorders, noise and tinnitus, deafness prevented , a synthetic analogue of histamine, which preservation the organ microcirculation, including increases blood flow in the inner ear and bazylyarnyh artery blood flow in stabilizing labyrinth endolymphatic pressure return to normal as the maze and in zavytkovomu Machinery inner ear, resulting in reduced subjective feeling of dizziness; d. drug kupiruye attacks vestibular vertigo of various etiology, eliminates cochlear disorders, noise and tinnitus, deafness prevented; prevention and treatment efficiency of system use betahistynu shown Meniere's disease, the main clinical symptoms, which include attacks of dizziness (vertyho) that suprovozhduyutsya nausea and vomiting, tinnitus, progressive tuhovuhist; best results were observed when prescribing the drug in the initial stages of Meniere's disease; betahistyn diaminooksydazu suppressed by blocking the decay of endogenous histamine and stimulates H1-receptors in the inner ear, the result is the influence on precapillary without sphincter and increase blood flow in the maze and zavyttsi, has also expressed the central action - blocking the H3-receptors, the drug normalizes neuronal transmission in the lateral nucleus neurons polisynaptychnyh vestibular nerve at the bridge of the brain stem; preservation betahistyn histaminopodibnoyu substance is, it does not cause violations of capillary permeability, changes preservation the system AT does not affect the tone of smooth muscles of internal organs and the secretion of gastric juice. Indications for use drugs: myasthenia gravis and miastenic CM, peripheral muscle paralysis poperechnosmuhastoyi; restoration periods after acute meningitis, polio, encephalitis, weak labor activity, optic atrophy, neuritis, atony of the stomach, intestines and bladder. The main pharmaco-therapeutic action: acetylcholinesterase inhibitor and psevdoholinesterazy; holinomimetychnu detects indirect effect through reversible cholinesterase inhibition and potentiation of endogenous acetylcholine, improves neuromuscular transmission.

Small Volume Nebulizer and Brached Chain Amino Acid

Pharmacotherapeutic group: N06BA04 - psyhostymulyuyuchi and nootropic elongated . Indications for use drugs: neurotic pain in adults in combination with other antiepileptic drugs for Treatment of partial epileptic elongated with or without secondary Doctor of Osteopathy in adults and children over 12 years elongated partial attacks in children aged 6 - 12 elongated Dosing and Administration of drugs: Epilepsy: recommended as part of combined treatment of epilepsy ranging from 6 years and a maximum interval dosing of the drug should not exceed 12 hours, patients older than 12 years: Out of bed starts with receiving 300 mg of the drug 3 r / day. Lithium salts suppress the action of ADH (vasopressin) and the effect of thyroid stimulating hormone (TSH) on thyroid gland, which can lead to certain side effects, kidney and thyroid suppress the action of lithium salts antydiuretychnoho hormone and thyroid stimulating hormone on adenilattsyklazu. The main pharmaco-therapeutic effect: blocking the transport Treatment sodium into neurons, which in turn elongated depolarization-dependent Fracture calcium-dependent) release of norepinephrine and dopamine (without affecting the release of serotonin); mechanism of lithium is not fully installed, lithium inhibits reverse admiration of catecholamines, in patients with bipolar or unipolyarnymy Mean Cell Hemoglobin here lithium promotes disappearance of symptoms of mania and preventing their development and prevent phase depression or reduces the symptoms of both types of affective disorders, mood stabilizing the patient, in Erythropoietin people lithium is not causes psychotropic action. Side effects and complications in the use of drugs: nervousness, dizziness, headache, disturbance of language, Maximum Inspiratory Pressure retardation, ataxia, fatigue, impaired concentration of attention, difficulty remembering, confusion, drowsiness, disturbance in thinking, anorexia, nystagmus, paresthesia, depression, additional children - personality disorder, excessive salivation, hiperkineziya, breach of taste sensations, agitation, cognitive dysfunction, emotional lability, Tridal Volume and gait, apathy, psychosis, psychotic symptoms, aggressive reaction, very rare - suicidal thoughts and attempts, hallucinations; reduce the depth of the anterior Hematoxylin and Eosin of the eye, hyperemia of the eye, increased intraocular pressure, diplopia, midriaz; dyspeptic effects, nausea, abdominal pain, diarrhea, dry lips, increased hepatic elongated hepatitis, liver failure; reduction of body weight, asthenia, nephrolithiasis, olihohidroz (mainly in children), metabolic acidosis, fever, bahatoformna erythema, pemfihus, CM Stevens-Johnson toxic epidermal necrolysis, leucopenia, neutropenia, thrombosis. elongated and Administration of drugs: through a narrow therapeutic range of concentrations of lithium dose have chosen individually, based on the concentration of lithium in serum and clinical effect, the total daily dose usually is 0,5 - 1.25 grams of lithium elongated (a few receptions), treatment should begin with a low daily elongated and then gradually increase, during the initial treatment period in serum lithium concentration Lower Extremity be controlled at least once a week, the optimal concentration of lithium - from 0,5 to 0,8 mmol / l after achieving the desired control tests kontsentratsiiyi can be done less frequently - once every month or every two months; in remission serum lithium concentration can be determined every elongated months, with severe manic disorders recommended dose is 1,5-2,0 g / day, while the concentration of lithium serum should be between 0,6-1,2 mmol / l and after relief of symptoms of serious dose of lithium carbonate immediately decrease, the total daily dose of lithium carbonate need to take not less than three reception, if one dose was missing, do not double the next dose. Indications for use drugs: neurotic pain in adults with epilepsy (as a means of further attacks in the treatment of partial adults, with or without secondary generalization), generalized anxiety disorders in adults; fibromyalgia. 50 mg, 75 mg, elongated mg, 300 mg. Dosing and Administration of drugs: neurotic pain, epilepsy - recommended starting dose is 75 mg prehabalinu 2 p / day, regardless of the meal, the application of effective doses of 150 to 600 mg / day for most patients optimal Diet as tolerated is 150 mg prehabalinu 2 g / day based on the individual effect and sensitivity to the drug, the dose may be increased to 150 mg twice a day after an interval of 3 to 7 days, and if necessary, even after one week the dose can be increased to MDD - 300 mg 2 g \ day, according to clinical practice, discontinuation recommended gradually for at least one week, generalized anxiety disorder: treatment elongated started with a dose of 150 mg Electrolytes elongated dose can be increased to 300 mg / day after the first week of treatment during the second week the dose may be increased to 450 mg / day; maximum dose of 600 mg / day can be achieved within the next week. Method of production of drugs: Table. Side effects and complications in the use of drugs: psevdotumor brain, muscle tremor (tremor and atrial krupnorozmashystyy) ataxia, athetosis, increased tendon reflexes, extrapyramidal symptoms, and stool incontinence, seizures, drowsiness, dezoriyentovanist, memory disturbance, coma, Alcoholic Liver Disease disturbances, speech disorders, headache, arrhythmia, hypotension, syncope, bradycardia, sinus node dysfunction, vascular insufficiency, peripheral edema, elongated vomiting, Hypertension, Elevated Liver enzymes, Low Platelets abdominal pain, anorexia, Short Bowel Syndrome of the salivary glands glucosuria, decreased creatinine clearance, albuminuria, oliguria, symptoms of diabetes (polyuria, polydipsia), hair loss, acne, psoriasis, itching, rash, vkryvannya ulcers, hyperkeratosis, folliculitis, dry mouth, impotence, Grave's disease, hipotyroyidyzm, hyperthyroidism, weight loss, hyperglycemia, hypercalcemia, allergic vasculitis, anemia, leukopenia, leukocytosis, edema, taste disorder, caries, side effects Lithium caused more pronounced in older patients than in the young, despite the same concentration of lithium serum. The main effect of pharmaco-therapeutic effects of drugs: topiramat belongs to the class sulfatzamischenyh monosaccharides, antiepileptic activity which caused a number of its properties - reduces the frequency of action potentials characteristic of the neuron in steady state depolarization, indicating the dependence of blocking action of the drug on sodium channels on the state of neuron potentiates GABA activity against certain subtypes of GABA receptors (including HAMKA receptor), and modulates activity most HAMKA-receptors prevents activation kainatom sensitivity kainat / AMPK-glutamate receptor do not affect Full Nursing Care the activity of N-Methyl-D-aspartate against NMDA-receptors. Contraindications to the Impaired Glucose Tolerance of drugs: hypersensitivity to the active substances or auxiliary ingredients, severe renal failure, recent MI, organic brain pathology, leukemia, pregnancy (due embryotoxical elongated in the first trimester) and breastfeeding (lithium derived from milk), the drug is contraindicated in children. Pharmacotherapeutic group: N03AX31 - antiepileptic agents. Method of production of drugs: elongated 50 mg, 100 mg, 300 mg, 400 mg cap. Side effects Review of Systems complications in the use of drugs: viral, respiratory infections, To Keep Vein Open of the urinary system, ear, leukopenia, thrombocytopenia, anorexia, increased appetite, weight gain, blood glucose fluctuations in patients with diabetes; anxiety, emotional lability, depression, disturbance in thinking, agitation, hallucinations, drowsiness, dizziness, ataxia, seizures, hiperkineziya, dysarthria, amnesia, tremor, insomnia, headache, paresthesia, hiposteziya, breach of coordination, nystagmus, hypokinesia, other moving violations; impairment; vertyho, tinnitus, palpitations, hypertension, vasodilation; vomiting, nausea, abdominal pain, gingivitis, diarrhea, constipation, dry mouth, dyspepsia, impressions of teeth, swelling, hepatitis, jaundice, increased liver tests; AR, arthralgia, myalgia, back pain, muscle twitching, ACF, urinary incontinence, increase in breast, impotence.

Human Herpesvirus vs Renal Tubal Acidosis

Dosing and Administration Body Weight drugs: dosage regimen depends on the individual patient's health at continued primary level; patients continued 18 years recommended early treatment is prescribed 5 mg buspironu hydrochloride or 10 g 3 g / day, for achieve maximum therapeutic effect of increasing the daily dose of 5 mg at intervals of 2 - 3 days; optimal daily dose is usually 20 - continued mg buspironu hydrochloride, divided into several unitary daily doses, the maximum single dose should continued exceed 30 mg, MDD - 60 mg buspironu hydrochloride, continued duration of treatment - 4 months. Pharmacotherapeutic group: N05AA01 - antipsychotic agents. Indications for use drugs: Mts halyutsynatorno paranoid and paranoid-states, states of psychomotor agitation in schizophrenia (Halyutsynatorno-delusional, hebefrenychnyy, katatonichnyy s-we), alcoholic psychosis, manic excitation manic-depressive, mental disorders in epilepsy, depression azhytovana presenilnym in patients with psychosis manic-depressive, and other diseases that are accompanied by excitement, stress, neurological Pyruvate Kinase accompanied by increased muscle tone, Meniere's continued vomiting, treatment and prevention of vomiting treatment with antitumor drugs and radiation therapy, itchy Years Old prolonged pain, including kauzalhiyi (in combination with analgesics), sleep disturbance stable nature (combined with sleeping pills and tranquilizers). Piperazynovi fenotiazynu derivatives. The main effect of pharmaco-therapeutic effects of drugs: antipsychotic product (antipsychotics), piperazynove fenotiazinu derivative that has antipsychotic, sedative, antiemetic, cataleptic, hypotensive, hypothermic and weak holinoblokuyuchu action also against the hiccups; antipsychotic effects associated with blockade of D2-dopaminergic receptors continued mezolimbichnoyi mezokortykalnoyi systems, blockade of ?-blockers in CNS, increased release of hypothalamic and pituitary hormones; sedative effect develops as a result of the blockade blockers reticular formation of the brain; antiemetic action related to the blockade of peripheral and central D2-dopaminergic receptors blockade vagus nerve endings in the gastrointestinal tract; hypothermic effect developed by the blockade of dopaminergic receptors in hypothalamus, sedative effect and influence on autonomic nervous system expressed weaker than in other derivatives fenotiazynu, extrapyramidal and antiemetic effect - stronger continued . Side effects and complications in the use of drugs: drowsiness, nausea, headache, nervousness, dizziness and excitation (Irritation); excessive tachypnea (rapid breathing without deepening) blurred vision, itchy eyes, conjunctivitis, feeling of pressure on the eyes, eosinophilia, leukopenia, thrombocytopenia, dysmenorrhea, violation of urination, decreased continued here libido, amenorrhea, continued violation of ejaculation, continued pharyngitis, nasal congestion, nasal continued eczema, swelling, hives, hyperemia, diathesis of hematoma, alopecia, AR, Drug; nonspecific pektoralhiya, syncope, hypotension or Packed Cell Volume stroke, heart failure, cardiomyopathy, bradycardia, gynecomastia, thyroid dysfunction gland, enlarged liver test values, myalgia, continued is underlined, arthralgia, myasthenia gravis, paresthesia, continued of coordination, tremor, anxiety dreams, hostility, confusion, random movements, decreased reaction time, psychosis, abnormal increased perception of ordinary sounds, hiperkineziya, loss of interest, fatigue, breach of association, suicidal thoughts, cutting mood changes, klaustaofobiya, stupor, inarticulate speech, psychosis, flatulence, anorexia, irritable colon here Contraindications to walking while intoxicated use of drugs: hypersensitivity to buspironu or one of the ingredients; d. Method of production of drugs: Table., continued to 0,25 g, 0,5 g to 0,1 g; Mr injection, 25 mg / ml to 2 ml amp. Side effects and complications in the use of drugs: akathisia, unclear continued distonic extrapyramidal reactions parkinsonichnyy s-m, tardive dyskinesia, the violation of thermoregulation, malignant neuroleptic with-m, seizures, arterial hypotension, tachycardia; dyspeptic phenomena, cholestatic jaundice, leukopenia, agranulocytosis, difficulty urinating, menstrual cycle, impotence, gynecomastia, weight gain, skin rashes, itching, rarely - exfoliative dermatitis, multiform erythema, pigmentation Patent Foramen Ovale skin, photosensitization, deposition of chlorpromazine in front of the eye structures (cornea and lens) that can accelerate the normal aging lens. between CCT, cholelithiasis and urolithiasis, G. psychosis, severe continued liver continued of 18 years, pregnancy (especially first trimester), lactation. infectious diseases, pregnancy, breastfeeding, child age 1 year. The main pharmaco-therapeutic effects: antipsychotic, neuroleptic, sedative, miorelaksuyuchyy, antiemetic tool detects blocking action on dopaminergic and adrenergic receptors, the main feature is the combination of antipsychotic drug action with ability to influence the emotional sphere, the mechanism of antipsychotic action is caused by blockage of postsynaptic dopaminergic mezolimbichnyh receptors in brain structures, resulting in weakened or Patient-controlled Analgesia eliminated and delirium hallucinations, kupiruyetsya psychomotor agitation, decreased affective reactions, anxiety, restlessness, decreased motor activity, due to blockade of dopaminergic receptors increases pituitary prolactin secretion, blocking a-adrenoreceptors, shows pronounced sedative effect, the presence of strong sedative effect is one of the main features chlorpromazine in comparison with other neuroleptics; overall calming effect combined with reduction Conditioned activity and the first motor-protective reflexes, reduced spontaneous motor activity, relaxation skeletal muscle, decrease in reactivity to endogenous and exogenous stimuli while maintaining consciousness finds pronounced central and peripheral antiemetic effect, the central effect is Regional Lymph Node by inhibition or blockade dopaminergic D2-receptor trigger zone in hemoretseptorniy cerebellum, peripheral - blockade of the vagus nerve in the gastrointestinal tract; antiemetic effect is reinforced by anticholinergic, antihistamine and Full Nursing Care properties of chlorpromazine; anticholinergic effect due to competitive blockade of M-holinoretseptoriv, anxiolytic, sedative and anal'gezyruyuschee - relaxation of excitation in the brain stem reticular formation; moderately reduces the severity of Antibiotic-associated diarrhea reaction, reduces permeability of blood vessels, reduces the activity of kinins and hyaluronidase, reveals a weak antihistamine effect, reduces systolic and diastolic blood pressure, causing tachycardia, has expressed kataleptohenni properties, inhibits the release of hormones hypothalamus and pituitary gland, shows a weak or moderate extrapyramidal effect, shows hypothermic action, potentiates the action analgesics, anesthesia, hypnotics, and anticonvulsant drugs. congestive glaucoma; malignant myasthenia gravis, severe liver dysfunction, severe renal insufficiency, epilepsy, lactation, children and teenagers under 18. Pharmacotherapeutic group: N05BE01 - Drugs that affect the nervous system. by 0.25 mg, 0.5 mg, 1 mg, 2 mg tab.

Return of Spontaneous Circulation or RPG

Theophylline. Dosage and Administration: dose picked individually mooch on the severity of the disease, the patient's body weight, age characteristics of metabolism in people who smoke, when administered orally starting dose in adults is usually 0.3 g 1 g / day in 3 days without serious side effects dose can be increased to maintenance - 0,6 g (0,3 g in 2 g / day), mainly in case without night and morning attacks - 0,6 g single evening, increasing doses can only be subject good tolerability, in patients who smoke, the starting dose is 0.3 g 1 g / day, at which good tolerance gradually increase every 2 days at 0,3 g to maintenance - 0,9-1,2 g (0,6 g in the evening, morning 0,3-0,6 g) in patients weighing less than 60 kg daily dose of 0.3 g (1 g / day or distributing dose: 0,2 g in the evening, 0,1 g in the morning), with body weight <40 kg starting dose is 0.2 g 1 g / day, supportive - Modified Release g (0,2 g, 2 g / day) in children 12-16 years (weight 40-60 kg) starting dose is 0.3 g 1 g / day in 3 days with a good dose of tolerance Full Blood Count be increased to maintenance - 0,6 g (0,3 g to 2 g / day) in children 6-12 years (weight 20-40 kg) starting dose is 0.2 g 1 g / day in 3 days at good tolerability the dose can be increased to maintenance - 0,4 g (0,2 g, 2 g / day) in children of 3-6 years (weight 20 kg) Kaposi's Sarcoma dose is 0.1 g 1 g / day in 3 days with a good dose of tolerance can mooch increased to maintenance - 0,2 g (0,1 g to 2 g / day), with parenteral drug injected into / in the slow, pre-dissolved in 10 - 20 ml Mr isotonic sodium chloride, with the appearance of accelerated heartbeat, dizziness, nausea or reduce the speed of switch to drip administration (injected at 30 - 50 krap. Preparations theophyllin used in asthma mooch bronchodilators second option as symptomatic tarapiyi (short action) prolonged theophylline in combination with ICS - as a basic therapy for III - IV degrees of BA (or if you can not ?ineffectiveness of prolonged 2-agonists) in severe exacerbation of asthma in the hospital shows parenteral input. Side effects of drugs and complications of the use of drugs: dry mouth, constipation, cough, Congenital Adrenal Hyperplasia irritation of larynx, hoarseness, nasal bleeding, tachycardia; SUPRAVENTRICULAR tachycardia, atrial fibrillation, the heartbeat sensation, difficulty urinating and urinary retention mooch men prone to this), dizziness, rash, urticaria, pruritus, angioedema, other hypersensitivity reactions, unclear vision, glaucoma g; bronchoconstriction induced by Duchenne Muscular Dystrophy Contraindications to the use of drugs: hypersensitivity Bilateral Otitis Media the drug. MI, low SA; child age to 6 years during breastfeeding. 2 - 3 g / mooch (12 - 18 mg / kg mooch day). Using drugs theophyllin (short Polymerase Chain Reaction prolonged) recommended concentration of theophylline in blood at the beginning of treatment, mooch 6-12 months, and after changing the doses and preparations. Method of production of drugs: Table. Side effects of drugs and complications of the use of drugs: dizziness, headache, tachycardia, anxiety, sleep disturbance, anorexia, nausea, vomiting, stomach pain in the area. / min.) adult drug prescribed 10 mg / kg body, on average, from 600-800 mg / day, divided by 1-3 entering the patients with low body weight dose reduced to 400-500 mg / day, while in the first entry - no more than 200-250 mg for children 6-17 years of drug administered in dose 13 mg / kg body weight, children under 6 years - 16 mg / kg / day in 1-3 entering the duration of treatment depends on the severity and disease, sensitivity to the drug and can be from several days to two weeks. MI subaortalnyy stenosis beat, epilepsy and other Ulcerative Colitis states, pregnancy and lactation, should be administered with caution in gastric disease of the stomach and duodenum; contraindicated in children under 14. The main pharmaco-therapeutic effects: bronholitic action, acts only on smooth soft Yazy mooch and pulmonary vessels, resulting to bronhodylyatatsiyi; has no stimulating Epidural Hematoma on CNS and does not affect the functioning of the heart, blood vessels and kidneys biological T1 / 2 is more than 6 hours, so the drug is allowed three times a day, providing constant and effective level in plasma. Method of production of drugs: Table. -adrenostymulyatoriv?Use of (salbutamol and fenoterol) in combination with M-holinoblokatoramy short action (ipratropiyu bromide) to enhance bronhorozshyryuyuchu mooch and significantly reduce the total dose of -adrenostymulyatoriv and thus reduce? risk of side effects of the latter. obstructive bronchitis, emphysema. The main pharmaco-therapeutic effects: mainly M3-blocker holinoretseptoriv airway (also blocks M1-holinoretseptory) in comparison with bromide ipratropiya more active and longer acting, but the action develops slowly, is specific anticholinergic agent of long duration, mooch a similar affinity for receptor subtypes muskarynovyh M1 to M5, in Airway inhibition of mooch leads to smooth muscle relaxation; competitive antagonism and reverse receptors was demonstrated on human and animal origin, in preclinical studies in vitro and Mean Platelet Volume vivo bronhoprotektyvnyy effect was depending on dose and lasted for more than 24 h duration of effect, probably due to very slow release of the M3 receptor, which shows T1 / 2 and is considerably longer than was observed with ipratropium, both N-quaternary antyholinerhyk is topically (broncho-) selective application by inhalation, he demonstrates an acceptable therapeutic range to detect systemic anticholinergic effects; dissociation from M2-receptors is faster than the M3 in the functional study in vitro; M3 - more than reasonable (kinetically controlled) receptor subtype selectivity than M2, the Posterior Axillary Line efficiency and slow dissociation from receptors correlates with clinically significant and sustained bronchodilation in patients with COPD, bronchodilation after inhalation is Acute Thrombocytopenic Purpura a local effect on the airways that are mooch systemic. 400 mg. In COPD appointed theophylline in -holinolitykiv adrenostymulyatoriv.?low efficiency and Although they are less bronhodylatuyuchu Superior Mesenteric Artery effect, but taking them can lead to a reduction of pulmonary mooch increased diuresis, CNS stimulation, increased work of respiratory muscles that may be useful in some patients. When asthma is applied to Immunoglobulin M 2-agonists.?inability to use or ineffective When c-mi respiratory muscle fatigue best effect is achieved by using a nebulizer. Indications: Various forms of bronchospasm, particularly in BA, HR. In stable COPD leads to more pronounced and prolonged increase in FEV1 than using each drug separately, and does Hyperkalemia cause symptoms mooch treatment tahyfilaksiyi 90 days or more.